QY Research > レポート一覧 > メディカルケア > プラズマ成分世界市場の発展状況と動向 2024-2030

プラズマ成分世界市場の発展状況と動向 2024-2030

英文タイトル: Global Plasma Fraction Market Insights, Forecast to 2030

プラズマ成分世界市場の発展状況と動向 2024-2030
  • レポートID:276807
  • 発表時期:2024-04-25
  • 訪問回数:724
  • ページ数:95
  • レポート形式:PDF
  • レポート言語:英語、日本語
  • グラフ数:110
  • レポートカテゴリ: メディカルケア

販売価格(消費税別)

販売価格(消費税別)

  •  
  • 個人版

    詳細
  • マルチユーザー版

    詳細
  • 企業版

    詳細

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。

英語版
日本語版
英語と日本語版

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。

shenQingYangBen

お見積

shenQingYangBen

サンプルお申込み

※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

biaoTi

概要

本報告書はプラズマ成分市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートはプラズマ成分の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界のプラズマ成分市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートはプラズマ成分のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別にプラズマ成分市場を分類しています。本研究に含まれる主な企業は:Baxter、Octapharma、Biotest、CSL、Grifols、Kedrion、LFB、Chinese Biological Products、Shanghai RAAS Blood Products

地域別市場区分、地域別分析は以下の通り:
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント:
Protease Inhibitors
Protease
Fibrinolytic Proteins
Coagulation Factors
Anti-Coagulant Proteins

用途別の市場セグメント:
Hospitals
Clinics
Ambulatory Surgical Centers

レポートの詳細内容
世界のプラズマ成分市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、プラズマ成分タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業のプラズマ成分収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のプラズマ成分市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、プラズマ成分市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

プラズマ成分のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
1章:プラズマ成分のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント(製品タイプ、用途など)のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。(20192030
2章:プラズマ成分の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。(20192030
3プラズマ成分企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。(20192030
4章:各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(20192024
5章:プラズマ成分の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。(20192030
6章:北米(米国、カナダ)のタイプ別、アプリケーション別、国別、各セグメントの収益。(20192030
7章:ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。(20192030
8章:中国の種類別、および用途別、各セグメントの収益。(20192030
9章アジア(中国を除く)の種類別、用途別、地域別、セグメントごとの収益。(20192030
10章:中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。(20192030
11章:プラズマ成分の主要企業の概要を提供し、製品の説明と仕様、プラズマ成分の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。(20192024
12章:アナリストの見解/結論

biaoTi

概要

Blood plasma fractionation refers to the general processes of separating the various components of blood plasma, which in turn is a component of blood obtained through blood fractionation.

Market Analysis and Insights: Global Plasma Fraction Market
The global Plasma Fraction market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers:
This report presents an overview of global market for Plasma Fraction market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Plasma Fraction, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Plasma Fraction, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Plasma Fraction revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Plasma Fraction market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Plasma Fraction revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Baxter, Octapharma, Biotest, CSL, Grifols, Kedrion, LFB, Chinese Biological Products and Shanghai RAAS Blood Products, etc.

Market Segmentation
By Company
    Baxter
    Octapharma
    Biotest
    CSL
    Grifols
    Kedrion
    LFB
    Chinese Biological Products
    Shanghai RAAS Blood Products

Segment by Type
    Protease Inhibitors
    Protease
    Fibrinolytic Proteins
    Coagulation Factors
    Anti-Coagulant Proteins

Segment by Application
    Hospitals
    Clinics
    Ambulatory Surgical Centers

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Plasma Fraction in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plasma Fraction companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plasma Fraction revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
biaoTi

総目録

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasma Fraction Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Protease Inhibitors
1.2.3 Protease
1.2.4 Fibrinolytic Proteins
1.2.5 Coagulation Factors
1.2.6 Anti-Coagulant Proteins
1.3 Market by Application
1.3.1 Global Plasma Fraction Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Plasma Fraction Market Perspective (2019-2030)
2.2 Global Plasma Fraction Growth Trends by Region
2.2.1 Plasma Fraction Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Plasma Fraction Historic Market Size by Region (2019-2024)
2.2.3 Plasma Fraction Forecasted Market Size by Region (2025-2030)
2.3 Plasma Fraction Market Dynamics
2.3.1 Plasma Fraction Industry Trends
2.3.2 Plasma Fraction Market Drivers
2.3.3 Plasma Fraction Market Challenges
2.3.4 Plasma Fraction Market Restraints

3 Competition Landscape by Key Players
3.1 Global Revenue Plasma Fraction by Players
3.1.1 Global Plasma Fraction Revenue by Players (2019-2024)
3.1.2 Global Plasma Fraction Revenue Market Share by Players (2019-2024)
3.2 Global Plasma Fraction Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Plasma Fraction, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Plasma Fraction Market Concentration Ratio
3.4.1 Global Plasma Fraction Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasma Fraction Revenue in 2023
3.5 Global Key Players of Plasma Fraction Head office and Area Served
3.6 Global Key Players of Plasma Fraction, Product and Application
3.7 Global Key Players of Plasma Fraction, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans

4 Plasma Fraction Breakdown Data by Type
4.1 Global Plasma Fraction Historic Market Size by Type (2019-2024)
4.2 Global Plasma Fraction Forecasted Market Size by Type (2025-2030)

5 Plasma Fraction Breakdown Data by Application
5.1 Global Plasma Fraction Historic Market Size by Application (2019-2024)
5.2 Global Plasma Fraction Forecasted Market Size by Application (2025-2030)

6 North America
6.1 North America Plasma Fraction Market Size (2019-2030)
6.2 North America Plasma Fraction Market Size by Type
6.2.1 North America Plasma Fraction Market Size by Type (2019-2024)
6.2.2 North America Plasma Fraction Market Size by Type (2025-2030)
6.2.3 North America Plasma Fraction Market Share by Type (2019-2030)
6.3 North America Plasma Fraction Market Size by Application
6.3.1 North America Plasma Fraction Market Size by Application (2019-2024)
6.3.2 North America Plasma Fraction Market Size by Application (2025-2030)
6.3.3 North America Plasma Fraction Market Share by Application (2019-2030)
6.4 North America Plasma Fraction Market Size by Country
6.4.1 North America Plasma Fraction Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Plasma Fraction Market Size by Country (2019-2024)
6.4.3 North America Plasma Fraction Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada

7 Europe
7.1 Europe Plasma Fraction Market Size (2019-2030)
7.2 Europe Plasma Fraction Market Size by Type
7.2.1 Europe Plasma Fraction Market Size by Type (2019-2024)
7.2.2 Europe Plasma Fraction Market Size by Type (2025-2030)
7.2.3 Europe Plasma Fraction Market Share by Type (2019-2030)
7.3 Europe Plasma Fraction Market Size by Application
7.3.1 Europe Plasma Fraction Market Size by Application (2019-2024)
7.3.2 Europe Plasma Fraction Market Size by Application (2025-2030)
7.3.3 Europe Plasma Fraction Market Share by Application (2019-2030)
7.4 Europe Plasma Fraction Market Size by Country
7.4.1 Europe Plasma Fraction Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Plasma Fraction Market Size by Country (2019-2024)
7.4.3 Europe Plasma Fraction Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries

8 China
8.1 China Plasma Fraction Market Size (2019-2030)
8.2 China Plasma Fraction Market Size by Type
8.2.1 China Plasma Fraction Market Size by Type (2019-2024)
8.2.2 China Plasma Fraction Market Size by Type (2025-2030)
8.2.3 China Plasma Fraction Market Share by Type (2019-2030)
8.3 China Plasma Fraction Market Size by Application
8.3.1 China Plasma Fraction Market Size by Application (2019-2024)
8.3.2 China Plasma Fraction Market Size by Application (2025-2030)
8.3.3 China Plasma Fraction Market Share by Application (2019-2030)

9 Asia (excluding China)
9.1 Asia Plasma Fraction Market Size (2019-2030)
9.2 Asia Plasma Fraction Market Size by Type
9.2.1 Asia Plasma Fraction Market Size by Type (2019-2024)
9.2.2 Asia Plasma Fraction Market Size by Type (2025-2030)
9.2.3 Asia Plasma Fraction Market Share by Type (2019-2030)
9.3 Asia Plasma Fraction Market Size by Application
9.3.1 Asia Plasma Fraction Market Size by Application (2019-2024)
9.3.2 Asia Plasma Fraction Market Size by Application (2025-2030)
9.3.3 Asia Plasma Fraction Market Share by Application (2019-2030)
9.4 Asia Plasma Fraction Market Size by Region
9.4.1 Asia Plasma Fraction Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Plasma Fraction Market Size by Region (2019-2024)
9.4.3 Asia Plasma Fraction Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia

10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Plasma Fraction Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Plasma Fraction Market Size by Type
10.2.1 Middle East, Africa, and Latin America Plasma Fraction Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Plasma Fraction Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Plasma Fraction Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Plasma Fraction Market Size by Application
10.3.1 Middle East, Africa, and Latin America Plasma Fraction Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Plasma Fraction Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Plasma Fraction Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Plasma Fraction Market Size by Country
10.4.1 Middle East, Africa, and Latin America Plasma Fraction Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Plasma Fraction Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Plasma Fraction Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries

11 Key Players Profiles
11.1 Baxter
11.1.1 Baxter Company Details
11.1.2 Baxter Business Overview
11.1.3 Baxter Plasma Fraction Introduction
11.1.4 Baxter Revenue in Plasma Fraction Business (2019-2024)
11.1.5 Baxter Recent Developments
11.2 Octapharma
11.2.1 Octapharma Company Details
11.2.2 Octapharma Business Overview
11.2.3 Octapharma Plasma Fraction Introduction
11.2.4 Octapharma Revenue in Plasma Fraction Business (2019-2024)
11.2.5 Octapharma Recent Developments
11.3 Biotest
11.3.1 Biotest Company Details
11.3.2 Biotest Business Overview
11.3.3 Biotest Plasma Fraction Introduction
11.3.4 Biotest Revenue in Plasma Fraction Business (2019-2024)
11.3.5 Biotest Recent Developments
11.4 CSL
11.4.1 CSL Company Details
11.4.2 CSL Business Overview
11.4.3 CSL Plasma Fraction Introduction
11.4.4 CSL Revenue in Plasma Fraction Business (2019-2024)
11.4.5 CSL Recent Developments
11.5 Grifols
11.5.1 Grifols Company Details
11.5.2 Grifols Business Overview
11.5.3 Grifols Plasma Fraction Introduction
11.5.4 Grifols Revenue in Plasma Fraction Business (2019-2024)
11.5.5 Grifols Recent Developments
11.6 Kedrion
11.6.1 Kedrion Company Details
11.6.2 Kedrion Business Overview
11.6.3 Kedrion Plasma Fraction Introduction
11.6.4 Kedrion Revenue in Plasma Fraction Business (2019-2024)
11.6.5 Kedrion Recent Developments
11.7 LFB
11.7.1 LFB Company Details
11.7.2 LFB Business Overview
11.7.3 LFB Plasma Fraction Introduction
11.7.4 LFB Revenue in Plasma Fraction Business (2019-2024)
11.7.5 LFB Recent Developments
11.8 Chinese Biological Products
11.8.1 Chinese Biological Products Company Details
11.8.2 Chinese Biological Products Business Overview
11.8.3 Chinese Biological Products Plasma Fraction Introduction
11.8.4 Chinese Biological Products Revenue in Plasma Fraction Business (2019-2024)
11.8.5 Chinese Biological Products Recent Developments
11.9 Shanghai RAAS Blood Products
11.9.1 Shanghai RAAS Blood Products Company Details
11.9.2 Shanghai RAAS Blood Products Business Overview
11.9.3 Shanghai RAAS Blood Products Plasma Fraction Introduction
11.9.4 Shanghai RAAS Blood Products Revenue in Plasma Fraction Business (2019-2024)
11.9.5 Shanghai RAAS Blood Products Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

biaoTi

表と図のリスト

List of Tables
    Table 1. Global Plasma Fraction Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Protease Inhibitors
    Table 3. Key Players of Protease
    Table 4. Key Players of Fibrinolytic Proteins
    Table 5. Key Players of Coagulation Factors
    Table 6. Key Players of Anti-Coagulant Proteins
    Table 7. Global Plasma Fraction Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 8. Global Plasma Fraction Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Plasma Fraction Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Plasma Fraction Market Share by Region (2019-2024)
    Table 11. Global Plasma Fraction Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Plasma Fraction Market Share by Region (2025-2030)
    Table 13. Plasma Fraction Market Trends
    Table 14. Plasma Fraction Market Drivers
    Table 15. Plasma Fraction Market Challenges
    Table 16. Plasma Fraction Market Restraints
    Table 17. Global Plasma Fraction Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Plasma Fraction Revenue Share by Players (2019-2024)
    Table 19. Global Top Plasma Fraction by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Fraction as of 2023)
    Table 20. Global Plasma Fraction Industry Ranking 2022 VS 2023 VS 2024
    Table 21. Global 5 Largest Players Market Share by Plasma Fraction Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Global Key Players of Plasma Fraction, Headquarters and Area Served
    Table 23. Global Key Players of Plasma Fraction, Product and Application
    Table 24. Global Key Players of Plasma Fraction, Product and Application
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Plasma Fraction Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Plasma Fraction Revenue Market Share by Type (2019-2024)
    Table 28. Global Plasma Fraction Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Plasma Fraction Revenue Market Share by Type (2025-2030)
    Table 30. Global Plasma Fraction Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Plasma Fraction Revenue Share by Application (2019-2024)
    Table 32. Global Plasma Fraction Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Plasma Fraction Revenue Share by Application (2025-2030)
    Table 34. North America Plasma Fraction Market Size by Type (2019-2024) & (US$ Million)
    Table 35. North America Plasma Fraction Market Size by Type (2025-2030) & (US$ Million)
    Table 36. North America Plasma Fraction Market Size by Application (2019-2024) & (US$ Million)
    Table 37. North America Plasma Fraction Market Size by Application (2025-2030) & (US$ Million)
    Table 38. North America Plasma Fraction Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 39. North America Plasma Fraction Market Size by Country (2019-2024) & (US$ Million)
    Table 40. North America Plasma Fraction Market Size by Country (2025-2030) & (US$ Million)
    Table 41. Europe Plasma Fraction Market Size by Type (2019-2024) & (US$ Million)
    Table 42. Europe Plasma Fraction Market Size by Type (2025-2030) & (US$ Million)
    Table 43. Europe Plasma Fraction Market Size by Application (2019-2024) & (US$ Million)
    Table 44. Europe Plasma Fraction Market Size by Application (2025-2030) & (US$ Million)
    Table 45. Europe Plasma Fraction Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Europe Plasma Fraction Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Europe Plasma Fraction Market Size by Country (2025-2030) & (US$ Million)
    Table 48. China Plasma Fraction Market Size by Type (2019-2024) & (US$ Million)
    Table 49. China Plasma Fraction Market Size by Type (2025-2030) & (US$ Million)
    Table 50. China Plasma Fraction Market Size by Application (2019-2024) & (US$ Million)
    Table 51. China Plasma Fraction Market Size by Application (2025-2030) & (US$ Million)
    Table 52. Asia Plasma Fraction Market Size by Type (2019-2024) & (US$ Million)
    Table 53. Asia Plasma Fraction Market Size by Type (2025-2030) & (US$ Million)
    Table 54. Asia Plasma Fraction Market Size by Application (2019-2024) & (US$ Million)
    Table 55. Asia Plasma Fraction Market Size by Application (2025-2030) & (US$ Million)
    Table 56. Asia Plasma Fraction Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 57. Asia Plasma Fraction Market Size by Region (2019-2024) & (US$ Million)
    Table 58. Asia Plasma Fraction Market Size by Region (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Plasma Fraction Market Size by Type (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Plasma Fraction Market Size by Type (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Plasma Fraction Market Size by Application (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Plasma Fraction Market Size by Application (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Plasma Fraction Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 64. Middle East, Africa, and Latin America Plasma Fraction Market Size by Country (2019-2024) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Plasma Fraction Market Size by Country (2025-2030) & (US$ Million)
    Table 66. Baxter Company Details
    Table 67. Baxter Business Overview
    Table 68. Baxter Plasma Fraction Product
    Table 69. Baxter Revenue in Plasma Fraction Business (2019-2024) & (US$ Million)
    Table 70. Baxter Recent Developments
    Table 71. Octapharma Company Details
    Table 72. Octapharma Business Overview
    Table 73. Octapharma Plasma Fraction Product
    Table 74. Octapharma Revenue in Plasma Fraction Business (2019-2024) & (US$ Million)
    Table 75. Octapharma Recent Developments
    Table 76. Biotest Company Details
    Table 77. Biotest Business Overview
    Table 78. Biotest Plasma Fraction Product
    Table 79. Biotest Revenue in Plasma Fraction Business (2019-2024) & (US$ Million)
    Table 80. Biotest Recent Developments
    Table 81. CSL Company Details
    Table 82. CSL Business Overview
    Table 83. CSL Plasma Fraction Product
    Table 84. CSL Revenue in Plasma Fraction Business (2019-2024) & (US$ Million)
    Table 85. CSL Recent Developments
    Table 86. Grifols Company Details
    Table 87. Grifols Business Overview
    Table 88. Grifols Plasma Fraction Product
    Table 89. Grifols Revenue in Plasma Fraction Business (2019-2024) & (US$ Million)
    Table 90. Grifols Recent Developments
    Table 91. Kedrion Company Details
    Table 92. Kedrion Business Overview
    Table 93. Kedrion Plasma Fraction Product
    Table 94. Kedrion Revenue in Plasma Fraction Business (2019-2024) & (US$ Million)
    Table 95. Kedrion Recent Developments
    Table 96. LFB Company Details
    Table 97. LFB Business Overview
    Table 98. LFB Plasma Fraction Product
    Table 99. LFB Revenue in Plasma Fraction Business (2019-2024) & (US$ Million)
    Table 100. LFB Recent Developments
    Table 101. Chinese Biological Products Company Details
    Table 102. Chinese Biological Products Business Overview
    Table 103. Chinese Biological Products Plasma Fraction Product
    Table 104. Chinese Biological Products Revenue in Plasma Fraction Business (2019-2024) & (US$ Million)
    Table 105. Chinese Biological Products Recent Developments
    Table 106. Shanghai RAAS Blood Products Company Details
    Table 107. Shanghai RAAS Blood Products Business Overview
    Table 108. Shanghai RAAS Blood Products Plasma Fraction Product
    Table 109. Shanghai RAAS Blood Products Revenue in Plasma Fraction Business (2019-2024) & (US$ Million)
    Table 110. Shanghai RAAS Blood Products Recent Developments
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Plasma Fraction Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Plasma Fraction Market Share by Type: 2023 VS 2030
    Figure 3. Protease Inhibitors Features
    Figure 4. Protease Features
    Figure 5. Fibrinolytic Proteins Features
    Figure 6. Coagulation Factors Features
    Figure 7. Anti-Coagulant Proteins Features
    Figure 8. Global Plasma Fraction Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Plasma Fraction Market Share by Application: 2023 VS 2030
    Figure 10. Hospitals Case Studies
    Figure 11. Clinics Case Studies
    Figure 12. Ambulatory Surgical Centers Case Studies
    Figure 13. Plasma Fraction Report Years Considered
    Figure 14. Global Plasma Fraction Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Plasma Fraction Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Plasma Fraction Market Share by Region: 2023 VS 2030
    Figure 17. Global Plasma Fraction Market Share by Players in 2023
    Figure 18. Global Top Plasma Fraction Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Fraction as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Plasma Fraction Revenue in 2023
    Figure 20. North America Plasma Fraction Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Plasma Fraction Market Share by Type (2019-2030)
    Figure 22. North America Plasma Fraction Market Share by Application (2019-2030)
    Figure 23. North America Plasma Fraction Market Share by Country (2019-2030)
    Figure 24. United States Plasma Fraction Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Plasma Fraction Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Plasma Fraction Market Size YoY (2019-2030) & (US$ Million)
    Figure 27. Europe Plasma Fraction Market Share by Type (2019-2030)
    Figure 28. Europe Plasma Fraction Market Share by Application (2019-2030)
    Figure 29. Europe Plasma Fraction Market Share by Country (2019-2030)
    Figure 30. Germany Plasma Fraction Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. France Plasma Fraction Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. U.K. Plasma Fraction Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Italy Plasma Fraction Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Russia Plasma Fraction Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Nordic Countries Plasma Fraction Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. China Plasma Fraction Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. China Plasma Fraction Market Share by Type (2019-2030)
    Figure 38. China Plasma Fraction Market Share by Application (2019-2030)
    Figure 39. Asia Plasma Fraction Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. Asia Plasma Fraction Market Share by Type (2019-2030)
    Figure 41. Asia Plasma Fraction Market Share by Application (2019-2030)
    Figure 42. Asia Plasma Fraction Market Share by Region (2019-2030)
    Figure 43. Japan Plasma Fraction Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. South Korea Plasma Fraction Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. China Taiwan Plasma Fraction Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Plasma Fraction Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. India Plasma Fraction Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Australia Plasma Fraction Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Plasma Fraction Market Size YoY (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Plasma Fraction Market Share by Type (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Plasma Fraction Market Share by Application (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Plasma Fraction Market Share by Country (2019-2030)
    Figure 53. Brazil Plasma Fraction Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Mexico Plasma Fraction Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Turkey Plasma Fraction Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Plasma Fraction Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Israel Plasma Fraction Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. GCC Countries Plasma Fraction Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Baxter Revenue Growth Rate in Plasma Fraction Business (2019-2024)
    Figure 60. Octapharma Revenue Growth Rate in Plasma Fraction Business (2019-2024)
    Figure 61. Biotest Revenue Growth Rate in Plasma Fraction Business (2019-2024)
    Figure 62. CSL Revenue Growth Rate in Plasma Fraction Business (2019-2024)
    Figure 63. Grifols Revenue Growth Rate in Plasma Fraction Business (2019-2024)
    Figure 64. Kedrion Revenue Growth Rate in Plasma Fraction Business (2019-2024)
    Figure 65. LFB Revenue Growth Rate in Plasma Fraction Business (2019-2024)
    Figure 66. Chinese Biological Products Revenue Growth Rate in Plasma Fraction Business (2019-2024)
    Figure 67. Shanghai RAAS Blood Products Revenue Growth Rate in Plasma Fraction Business (2019-2024)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
当社から購入のメリット
サンプル提供

01. サンプル提供

ご購入前にサンプル(英語、日本語)が提供可能。

カスタマイズサービス

02. カスタマイズサービス

レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。

プロフェッショナルな日本語翻訳

03. プロフェッショナルな日本語翻訳

AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。

多言語コミュニケーション

04. 多言語コミュニケーション

日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。

 お支払方法

05. お支払方法

銀行振込(納品後、ご請求書送付)。

アフターサービス

06. アフターサービス

ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。

ご注文方法

請求書払いの場合:

  • yuan01

    レポート選択

  • yuan01

    見積もり依頼

  • yuan01

    メールでのご注文

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)

  • yuan01

    決済(後払い)

クレジットカード決済の場合:

  • yuan01

    レポート選択

  • yuan01

    ウェブサイトでのご注文

  • yuan01

    決済

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)